Regulation of VIP production and secretion by murine lymphocytes

Journal of Neuroimmunology

Volumn 93, Issue 1-2, 1999, Pages 126-138

  Martinez, Carmen ^a   Delgado, Mario ^a   Abad, Catalina ^a   Gomariz, Rosa P ^a   Ganea, Doina ^b   Leceta, Javier ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

ELISA; Lymphocyte; Lymphoid organs; Neuroimmunomodulation; Vasoactive intestinal peptide

Indexed keywords

CONCANAVALIN A; DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECEPTOR ANTIBODY; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; T LYMPHOCYTE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOMODULATION; LYMPHOCYTE; LYMPHOID ORGAN; MALE; NONHUMAN; PEPTIDE SYNTHESIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; CARCINOGENS; CELL DIVISION; CELLS, CULTURED; DEXAMETHASONE; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEEDBACK; FLOW CYTOMETRY; FORSKOLIN; GLUCOCORTICOIDS; GRANULOCYTES; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; ISOQUINOLINES; LYMPH NODES; MACROPHAGES, PERITONEAL; MALE; MAST CELLS; MITOGENS; NEUROIMMUNOMODULATION; PERITONEUM; RATS; RATS, WISTAR; RETINALDEHYDE; SENSITIVITY AND SPECIFICITY; SPLEEN; SULFONAMIDES; TETRADECANOYLPHORBOL ACETATE; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032891615     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00216-1     Document Type: Article

References (57)

1. Bellinger D.L., Lorton D., Horn L., Brouxhon S., Felten S.Y., Felten D.L. Vasoactive intestinal polypeptide (VIP) innervation of rat spleen thymus and lymph nodes. Peptides. 8:1997;1139-1149.
2. Blalock J.E., Smith E.M. Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc. Natl. Acad. Sci. USA. 77:1980;5972-5974.
3. Blalock J.E. Production of peptide hormones and neurotransmitters by the immune system. Chem. Immunol. 52:1992;1-24.
4. Boige N., Aminaroff B., Munk A., Laburthe M. Forskolin stimulates adenylate cyclase in human colonic crypts: Interaction with VIP. Eur. J. Pharmacol. 101:1984;111-117.
5. Brandtzaeg P., Oktedalen O., Kierulf P., Opstad P.K. Elevated VIP and endotoxin plasma levels in human gram-negative septic shock. Regul. Pept. 24:1989;37-44.
6. Calvo J.R., Guerrero J.M., López-González A., Osuna C., Segura J.J. Characteristics of receptors for VIP in rat peritoneal macrophages. Peptides. 15:1994;309-315.
7. Calvo J.R., Pozo D., Guerrero J.M. Functional and molecular characterization of VIP receptor and signal transduction in human rodent immune systems. Adv. Neuroimmunol. 6:1996;39-47.
8. Chew L.J., Burke Z.D., Morgan H., Gozes I., Murphy D., Carter D.A. Transcription of the vasoactive intestinal peptide gene in response to glucocorticoids: differential regulation of alternative transcripts is modulated by a labile protein in rat anterior pituitary. Mol. Cell Endocrinol. 130:1997;83-91.
9. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., Naito K., Toshioka T., Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoleinsulfonamide (H89), of PC12D pheochro-mocytoma cells. J. Biol. Chem. 265:1990;5267-5272.
10. Clarke B.L., Gebhardt B.M., Blalock J.E. Mitogen-stimulated lymphocytes release biologically active corticotrophin. Endocrinology. 132:1993;983-988.
11. Cutz E., Chan W., Track N.S., Gooth A., Said S.I. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature. 275:1978;661-662.
12. Dardenne M., Savino W. Control of thymus physiology by peptidic hormones and neuropeptides. Immunol. Today. 15:1994;518-523.
13. Davidson A., Moody T.W., Gozes I. Regulation of VIP gene expression in general. J. Mol. Neurosci. 7:1996;99-110.
14. De la Fuente M., Delgado M., Gomariz R.P. VIP modulation of immune cell functions. Adv. Neuroimmunol. 6:1996;75-91.
15. Delgado M., Pozo D., Martínez C., Garrido E., Leceta J., Calvo J.R., Gomariz R.P. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages. Regul. Pept. 62:1996;161-166.
16. Delgado M., Martínez C., Johson M.C., Gomariz R.P., Ganea D. Differential expression of vasoactive intestinal peptide receptor 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. J. Neuroimmunol. 68:1996;27-38.
17. Delgado M., Garrido E., Martínez C., Leceta J., Gomariz R.P. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis. Blood. 12:1996;5152-5161.
18. 1 receptor gene expression in rat thymocyte subsets. Peptides. 17:1996;803-807.
19. Dimaline, R., 1989. Vasoactive intestinal polypeptide. In: Holmgren, S. (Ed.), Comparative Physiology of Regulatory Peptides. Chapman and Hall, Beckknham, England, pp. 150-173.
20. Eiden L.E., Hotchkiss A.J. Cyclic adenosine monophosphate regulates vasoactive intestinal polypeptide and enkephalin biosynthesis in cultured chromaffin cells. Neuropeptides. 4:1983;1-9.
21. Emanuele N.V., Emanuele M.A., Tentler J., Kirsteins L., Azad N., Lawrence A.M. Rat spleen lymphocytes contain an immunoreactive and bioactive luteinizing hormone-releasing hormone. Endocrinology. 126:1990;2482-2486.
22. Eskay R.L., Eiden L.E. Interleukin-1α and tumor necrosis factor-α differentially regulate enkephalin, Vasoactive Intestinal Polypeptide, Neurotensin, and Substance P biosynthesis in chromaffin cells. Endocrinology. 130:1992;2252-2258.
23. Fink J.S., Verhave M., Walton K., Mandel G., Goodman R.H. Cyclic AMP- and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J. Biol. Chem. 266:1991;3881-3887.
24. Fuller P.J., Verity K. Somatostatin gene expression in the thymus gland. J. Immunol. 143:1989;1015-1017.
25. Ganea D. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol. 6:1996;61-74.
26. Geenen V., Legros J.J., Franchimont P., Defresne M.P., Boniver J., Ivell R., Richter D. The thymus as a neuroendocrine organ: Synthesis of vasopressin and oxytocin in human thymic epithelium. Ann. Acad. NY Acad. Sci. 496:1987;56-66.
27. Goetzl E.J., Sreedharan S.P., Turck D.W. Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cell. J. Biol. Chem. 263:1988;9083-9086.
28. Goetzl E.J., Kodama K.T., Turck C.W., Schiogolev A.S., Sreedharan S.P. Unique pattern of cleavage of vasoactive intestinal peptide by human lymphocytes. Immunology. 66:1989;554-558.
29. Gomariz R.P., Lorenzo M.J., Cacicedo L., Vicente A., Zapata A. Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus. Brain Behav. Immun. 4:1990;151-161.
30. Gomariz R.P., De la Fuente M., Hernanz A., Leceta J. Occurrence of vasoactive intestinal peptide (VIP) in lymphoid organs from rat and mouse. Ann. NY Acad. Sci. 650:1992;13-18.
31. Gomariz R.P., Delgado M., Naranjo J.R., Mellstrom B., Tormo A., Mata F., Leceta J. VIP gene expression in rat thymus and spleen. Brain Behav. Immun. 7:1993;271-278.
32. Gomariz R.P., Leceta J., Garrido E., Garrido T., Delgado M. Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes. Regul. Pept. 50:1994;177-184.
33. Gomariz R.P., Garrido E., Leceta J., Martínez C., Abalo R., Delgado M. Gene expression of VIP receptor in rat lymphocytes. Biochem. Biophys. Res. Commun. 203:1994;1599-1604.
34. Gozes I., Brenneman D.E. VIP: Molecular biology and neurobiological function. Mol. Neurobiol. 3:1989;201-236.
35. Gutierrez M.A., Molina J.F., Cuellar M.L., García C., Gutierrez-Urena S., Charavi A., Espinoza L.R. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus. 4:1995;348-352.
36. Johnson M.C., McCormack R.J., Delgado M., Martínez C., Ganea D. Murine T lymphocytes express constitutive intestinal peptide receptor 1 (VIP-R1) mRNA. J. Neuroimmunol. 68:1996;109-119.
37. Kaltreider H.B., Ichikawa S., Byrd P.K., Ingram D.A., Kishiyama J.L., Sreedharan S.P., Warnock M.L., Beck J.M., Goetzl E.J. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am. J. Respir. Cell Mol. Biol. 16:1997;133-144.
38. Leceta J., Martínez M.C., Delgado M., Garrido E., Gomariz R.P. Lymphoid cell subpopulations containing vasoactive intestinal peptide in rat. Peptides. 15:1994;791-797.
39. Leceta J., Martínez C., Delgado M., Garrido E., Gomariz R.P. Expression of vasoactive intestinal peptide in lymphocytes: A possible endogenous role in regulation of the immune system. Adv. Neuroimmunol. 6:1996;29-36.
40. O'Dorisio M.S., O'Dorisio T.M., Cataland S., Balcerzak S.P. Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes. J. Lab. Clin. Med. 96:1980;666-672.
41. O'Neal K.D., Montgomery D.W., Truong T.M., Yu-Lee L.Y. Prolactin gene expression in human thymocytes. Mol. Cell. Endocrinol. 87:1992;R19-R23.
42. Pozo D., Delgado M., Martínez C., Gomariz R.P., Guerrero J.M., Calvo J.R. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages. Biochim. Biophys. Acta. 1359:1997;250-262.
43. Rawlings S.R. PACAP, PACAP receptors, and intracellular signalling. Mol. Cell. Endocrinol. 101:1994;C5-C9.
44. Rosen H., Behar O., Abramsky O., Ovadia H. Regulated expression of proenkephalin A in normal lymphocytes. J. Immunol. 143:1989;3703-3707.
45. Said S.I., Mutt V. Potent peripheral splanchnic vasodilator peptide from normal gut. Nature. 225:1970;863-864.
46. Santambrogio L., Benedetti M., Chao M.V., Muzaffar R., Kulig K., Gabellini N., Hochwald G. Nerve growth factor production by lymphocytes. J. Immunol. 153:1994;4488-4495.
47. Symes A.J., Lewis S.E., Corpus L., Rajan P., Hyman S.E., Fink J.S. STAT proteins participate in the regulation of the vasoactive intestinal peptide gene by ciliary neurotrophic factor family of cytokines. Mol. Endocrinol. 8:1994;1750-1763.
48. Taffet S.M., Greenfield A.R.L., Haddox M.K. Retinal inhibits TPA activated calcium-dependent, phospholipid-dependent protein kinase C. Biochem. Biophys. Res. Commun. 114:1983;1194-1199.
49. Tsukada T., Fink J.S., Mandel G., Goodman R.H. Identification of a region in the human vasoactive intestinal peptide gene responsible for regulation by cyclic AMP. J. Biol. Chem. 262:1987;8743-8747.
50. Vollmar A.K., Lang R.E., Hanze A., Schulz R. The rat thymus: a site of atrial natriuretic peptide synthesis. Peptides. 11:1990;33-37.
51. Waschek J.A., Hsu C.M., Eiden L.E. Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5′-flanking sequence. Proc. Natl. Acad. Sci. USA. 85:1988;9547-9551.
52. Weigent D.A., Baxter J.B., Wear W.E., Smith L.R., Bost K.L., Blalock E. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J. 2:1988;2812-2818.
53. Weigent D.A., Blalock E. Immunoreactive growth hormone-releasing factor in rat leukocytes. J. Neuroimmunol. 29:1990;1-13.
54. Weinstock J.V., Blum A., Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J. Immunol. 141:1989;961-966.
55. Weinstock J.V., Blum A.M. Detection of vasoactive intestinal peptide and localization of its mRNA within granulomas of murine schistosomiasis. Cell Immunol. 125:1990;291-300.
56. Wong H.C., Sternini C., Lloyd K., De Giorgio R., Walsh J.H. Monoclonal antibody to VIP: Production, characterization, immunoneutralizing activity, and usefulness in cytochemical staining. Hybridoma. 15:1996;133-139.
57. Zurawski G., Benedik M., Kamb B.J., Abrams J.S., Zurawski S.M., Lee F.D. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science. 232:1986;772-775.